The National Trial Lawyers
  • Home
    • Meet Our Team
    • Contact Us
    • Mission & Goals
    • FAQ
  • Webinars
  • News
  • Membership Directory
    • Top 100 Map – Civil Plaintiff
    • Top 100 Map – Criminal Defense
    • Top 40 Under 40 Map – Civil Plaintiff
    • Top 40 Under 40 Map – Criminal Defense
  • Top 100
    • Civil Plaintiff Officers / Executive Committee
    • Criminal Defense Officers / Executive Committee
    • Benefits
    • About
    • Top 100 President’s Message
    • Diplomat
    • Membership Renewal
    • Member Profile Updates
    • Top 100 Badge
    • Media
  • Top 40
    • Civil Plaintiff Officers / Executive Committee
    • Criminal Defense Officers / Executive Committee
    • Top 40 Under 40 Trial Academy Bootcamp
    • Benefits
    • About
    • Top 40 President’s Message
    • Membership Renewal
    • Member Profile Updates
    • Top 40 Badge
    • Media
  • Specialty Assoc
    • About
    • Shop
    • Officers
    • Membership Renewal
    • Member Profile Updates
    • Media
  • Nominate
    • Top 100
    • Top 40
    • Specialty Association
    • Trial Lawyer Hall of Fame
    • Trial Lawyer of the Year
    • Trial Team of the Year
    • America’s Most Influential Trial Lawyer
    • America’s Most Influential Law Firm
    • Lifetime Achievement Award
  • Shop
  • Magazine
    • A-List
  • Education and Networking Agenda
    • Trial Lawyers Summit
      • Summit Sponsors
    • Top 40 Under 40 Trial Academy Boot Camp
    • Mass Torts Made Perfect
    • The Lanier Master Class 5.0 Trial Academy 2021
    • Webinars
  • Hall of Fame
    • Trial Lawyer Hall of Fame

Stevens Johnson Syndrome: Zithromax Maker Warned About Zmax

Posted on March 12, 2013 by Andrew Findley


Lawyersandsettlements.com; March 11, 2013

New York, NY: Drug companies often face criticism that they downplay the risk of side effects, especially the risk of serious side effects such as Stevens Johnson Syndrome. In some cases, the US Food and Drug Administration (FDA) gets involved, as it did when it sent a warning letter about the risk of azithromycin side effects to the drug’s maker. Although many drugs linked to SJS include a warning about a possible allergic reaction, patients who developed SJS say the warning was not adequate, given the severity of the situation.
Many medications that have been linked to Stevens Johnson Syndrome do not give specific warnings about what the condition looks like or how serious it can be. They simply warn that an allergic reaction can occur and if a rash appears, the patient should seek medical attention. But in some cases the condition the medication is treating also causes a rash, causing patients to believe the rash is linked to their being ill, not to taking the medication.

Although technically Stevens Johnson Syndrome is indeed an allergic reaction to medication – even medication that has been previously tolerated by the patient – referring to Stevens Johnson Syndrome as an allergic reaction as opposed to a life-threatening reaction might not convey the severity of the situation.

Drug companies – including Pfizer, maker of Zithromax – have been warned by the FDA not to minimize the risks of Stevens Johnson Syndrome. On June 19, 2012, the FDA sent a warning letter to Pfizer (found online at www.fda.gov), regarding the company’s “1 Day. 1 Dose” brochure for a drug called Zmax (azithromycin extended-release medication). The agency warned Pfizer that its brochure did not explain the severity of Stevens Johnson Syndrome – which can be fatal – and further did not note that some patients experienced continued severe allergic symptoms even after they stopped taking Zmax (the warning label did note that some symptoms recurred without further exposure to the drug but did not note how severe those symptoms were).

Zmax is used to treat mild to moderate infections including acute bacterial sinusitis and community-acquired pneumonia. Stevens Johnson Syndrome is a potentially fatal allergic reaction to medications including azithromycin. It often starts with a rash and swelling, and develops to the point where the patient’s skin sloughs off. Often the patient suffers permanent scarring, organ damage and vision problems.

http://www.lawyersandsettlements.com/articles/zithromax-sjs-lawsuit/zithromax-side-effects-lawsuit-9-18547.html?utm_expid=3607522-0&utm_referrer=http%3A%2F%2Fwww.lawyersandsettlements.com%2F

Posted in Blog, Product Liability

Comments are closed.

Recent Posts

Toyota Will Pay $180M to Settle Violations of the Clean-Air Act

Toyota Will Pay $180M to Settle Violations of the Clean-Air Act

January 15th, 2021

The U.S. Department of Justice and U.S. Environmental Protection Agency (EPA) announced today that the United States has[Read More...]
Boeing's Insitu Will Pay $25M to Settle a Whistleblower Complaint About Used Drone Parts

Boeing's Insitu Will Pay $25M to Settle a Whistleblower Complaint About Used Drone Parts

January 13th, 2021

Bingen, Wash.-based Insitu, a Boeing subsidiary, has agreed to pay $25 million to settle allegations that it used recycl[Read More...]
Deutsche Bank Agrees to Settle Criminal and Civil Charges for $130M

Deutsche Bank Agrees to Settle Criminal and Civil Charges for $130M

January 11th, 2021

DEUTSCHE Bank AG agreed to pay US$130 million to settle criminal and civil charges that it bribed foreign officials and manip[Read More...]
Boeing Pays $2.5B to Settle Charges Tied to the 737 MAX Crashes

Boeing Pays $2.5B to Settle Charges Tied to the 737 MAX Crashes

January 8th, 2021

Boeing has agreed to pay just over $2.5 billion to resolve a federal charge of “criminal misconduct” for how its [Read More...]
Texas Attorney General Seeks $43M in Google Antitrust Lawsuit

Texas Attorney General Seeks $43M in Google Antitrust Lawsuit

January 6th, 2021

The mass exodus of Texas Attorney General Ken Paxton's top staff over accusations of bribery against their former boss has le[Read More...]

Contact Us | Terms of Use | Privacy Policy

Attorney information and content provided on this website is provided for the benefit of members of The National Trial Lawyers and as a public service by Legal Associations Management, Inc. The website and all data are the property of Legal Associations Management, Inc. Data, including without limitation attorney information and content, on the site may not be mined, sold, or used commercially for any purpose without the explicit written consent of Legal Associations Management, Inc. This site may not be accessed by any automated program for extracting data for any use. By accessing and using the site you agree that you will not develop, support or use software, devices, scripts, robots, or any other means or processes (including crawlers, browser plug-ins and add-ons, or any other technology) to scrape data or otherwise copy profiles and other data. Unauthorized use or attempted unauthorized use of this system may subject you to both civil and criminal penalties.